Royal National Orthopaedic Hospital
London, HA7 4LP, United Kingdom
Location status: Recruiting
NCT Number: NCT07104955
Multi-Disciplinary Team (MDT) meetings are crucial for planning patient care in the National Health Service (NHS), but they can be time-consuming and sometimes lack complete patient information. This can lead to delays in treatment decisions, potentially incomplete care plans, or the need to repeatedly discuss the same patient cases.
This study aims to test a new software called Salutare One Referral. One Referral is designed to make these meetings more efficient and effective. We want to see if this software can help healthcare staff prepare MDT referral information more easily and facilitate a more informed MDT discussion, which could lead to better patient care. If successful, this could help improve how MDTs operate across the NHS.
Interested in participating?
Request InfoAll sexes
Interventional
Not applicable
London, HA7 4LP, United Kingdom
Location status: Recruiting
This study aims to evaluate the safety, implementation effectiveness and feasibility of the Salutare One Referral software, a new tool designed to enhance Multi-Disciplinary Team (MDT) meetings. MDT meetings are recognized as the preferred means of delivering complex care for both chronic and acute diseases. However, there remains significant diversity in the purpose, structure, processes, and content of MDT meetings, as well as in how effectively they have been integrated into clinical practice.
Common issues observed in MDTs include:
Study Design: This is a "before and after" study, observing MDT operations without the software, then with the software, followed by another period without it. MDT members will use the Salutare One Referral software during their regular meetings and complete questionnaires about their experience. The study will also analyse pseudonymized patient data to assess any changes in MDT review effectiveness. If successful, this study could lead to more efficient and effective MDT meetings, potentially resulting in improved patient care coordination across the NHS.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use of the multi-disciplinary team (MDT) meeting software to submit, review and discuss referrals
Time frame: 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on safety and operational incidents
Time frame: 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on effectiveness (non-validated questionnaire)
Time frame: 8 weeks (4 MDT meetings) for complex MDTs or 4 weeks (8 MDT meetings) for high-volume MDTs
MDT panel participant feedback on acceptability (Software Usability Scale 0-100, higher score indicate a better outcome)
Contact information is provided by the study sponsor or research team.
Chris Dial
CONTACT
Liba Stones, MA, MBA
CONTACT
Salutare Group Ltd.
Industry
Single Cohort Before and After Mixed-methods Prospective Study to Investigate the Impact of the Salutare One Referral Software on Patient Outcomes, Safety and Effectiveness of Multi-Disciplinary Team (MDT) Meetings
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699276
Cancer (Solid Tumors), Cisplatin
Bangkok, Thailand
View Trial DetailsNCT07670234
Cancer (Solid Tumors), Interaction Drug Food
Rabat, Morocco
View Trial DetailsNCT07645261
Cancer (Advanced Stage), Cancer (Solid Tumors)
São Paulo, Brazil
View Trial DetailsNCT07484932
Cancer (Solid Tumors), Geriatric Oncology
Hong Kong
View Trial Details